# TEG Anticoagulation Monitoring During ECMO

> **NCT02271126** · PHASE1 · COMPLETED · sponsor: **Policlinico Hospital** · enrollment: 42 (actual)

## Conditions studied

- Extracorporeal Membrane Oxygenation Complication

## Interventions

- **DEVICE:** TEG monitoring
- **DEVICE:** APTT monitoring
- **DRUG:** Heparin

## Key facts

- **NCT ID:** NCT02271126
- **Lead sponsor:** Policlinico Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-02
- **Primary completion:** 2016-09
- **Final completion:** 2016-11-30
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2017-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02271126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02271126, "TEG Anticoagulation Monitoring During ECMO". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02271126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*